PUBLICATIONS
Publications
Advancing bronchiectasis care: from innovative treatments to global insights
We aim to make the results of our research free and accessible to all. You can find links to EMBARC publications below:
Pollock, J., Polverino, E., Dhar, R., et al. THORAX, 2025
Aspergillus Serologic findings and clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry
Pollock, J., Goeminne, P.C., Aliberti, S., et al. CHEST, 2025
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference
Chalmers, J.D., Goeminne, P.C., Ringshausen, F.C. Eur Respir Rev, 2024
Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.
Conceicao, M., Shteinberg M., Goeminne P.C. et al. Eur Respir Rev, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Spinou, A., Hererro-Cortina, B., Aliberti, S., et al. Eur Respir J, 2024
Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient survey
Spinou, A., Almagro, M., Harris, B., et al. Eur Respir J, 2024
Endotypes of exacerbation in bronchiectasis: an observational cohort study
Gao, Y., Richardson, H., Dicker, A.J., et al. Am J Respir Crit Care Med, 2024
Sputum metagenomics of people with bronchiectasis
Rosenboom, I., Thavarasa, A., Richardson, H., et al. ERJ Open Res, 2024
Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis
Conceição, M., Shteinberg, M., Goeminne, P., et al. Eur Respir Rev, 2024
Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey
Shteinberg, M., Spinou, A., Goeminne, P., et al. ERJ Open Res, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)
Polverino, E., Dimakou, K., Traversi, L., et al. J Allergy Clin Immunol, 2024
The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)
Polverino, E., De Soyza, A., Dimakou, K., et al. Am J Respir Crit Care Med, 2024
Airway IL-1B is related to disease severity and mucociliary function in bronchiectasis
Perea, L., Bottier, M., Cant, E., et al. Eur Respir J, 2024
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study
Pieters, A. L. P., van der Veer, T., Meerburg, J. J., et al. Am J Respir Crit Care Med, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Aliberti, S., Ringshausen, F. C., Dhar, R., et al. Eur Respir J, 2024
Clinical efficacy of Serum Anti-glycopeptidolipid Core IgA Antibody Test for Screening Nontuberculosis Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort study
Choi, H., Hughes, C., Eke, Z., et al. CHEST, 2024
Bronchiectasis management in adults: state of the art and future directions
Choi, H., McShane, P.J., Aliberti, S., et al. Eur Respir J, 2024
Rethinking bronchiectasis as an inflammatory disease
Long, M.B., Chotirmall, S.H., Shteinberg, M & Chalmers, J.D. Lancet Respir Med, 2024
The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis
Cordeiro, R., Choi, H., Haworth, C.S., Chalmers, J.D. CHEST, 2024
Airway ‘Resistotypes’ and clinical Outcomes in Bronchiectasis
Mac Aogain, M., Ivan F.X., Jaggi, T.K et al. AJRCCM, 2024
A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis
Long, M.B., Gilmour, A., Kehl, M., et al. AJRCCM, 2024
The Precision Medicine Era of Bronchiectasis
Chotirmall, S.H. & Chalmers, J.D. AJRCCM, 2024
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry
Dhar, R., Singh, S., Talwar, D., et al. Eur Respir J, 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
Chalmers, J. D., Polverino, E., Crichton, M. L., et al. Lancet Respir Med, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration
Chalmers, J.D., Aliberti, S., Altenburg, J., et al. Eur Respir J, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
Chalmers, J.D., Gupta, A., Chotirmall, S.H., et al. ERJ Open Res, 2023
Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients’ and physiotherapists’ practices
McLeese, R.H., O’Neill, K., O’Neill, B., et al. ERJ Open Res, 2023
Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study
Choi, H., Ryu, S., Keir, H.R., et al. Am J Respir Crit Care Med, 2023
Intermittent prophylactic antibiotics for bronchiectasis
Spencer, S., Donovan, T., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2022
Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study
Shoemark, A., Shteinberg, M., De Soyza, A., et al. AJRCCM, 2022.
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
Aliberti, S., Goeminne, P.C., O’Donnel, A.E., et al. Lancet Respir Med, 2022
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the ‘Chronic Obstructive Pulmonary disease-Bronchiectasis Association’
Huang, J.T.J., Cant, E., Keir, H.R., et al. AJRCCM, 2022
Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease
Hull, R.C., Huang, J.T.J., Barton, A.K., et al. CHEST, 2022
Heterogeneity of treatment response in bronchiectasis clinical trials
Sibila, O., Laserna, E., Shoemark, A., et al. Eur Respir J, 2022
Critical appraisal of international adult bronchiectasis guidelines using the AGREE II tool
Tejada, S., Ramirez-Estrada, S., Tejo, A.M., et al. Eur J Intern Med, 2022
ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group
Traversi, L., Miravitlles, M., Martinez-Garcia, M. A., et al. ERJ Open Res, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Shteinberg, M., Boyd, J., Aliberti, S., et al. ERJ Open Res, 2021
Patients’ perspectives on bronchiectasis: findings from a social media listening study
Delestre-Levai, I., Aliberti, S., Almagro, M., et al. ERJ Open Res, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
Keir, H.R., Shoemark, A., Dicker, A.J., et al. Lancet Respir Med, 2021
Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Crichton, M.L., Dudgeon, E.K., Shoemark, A., et al. Eur Respir J, 2021
BronchUK: protocol for an observational cohort study and biobank in bronchiectasis
De Soyza, A., Mawson, P., Hill, A.T., et al. ERJ Open Res, 2021
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study
Dicker, A.J., Lonergan, M. Keir, H.R., et al. The Lancet, 2021
Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries
Lee, H., Choi H., Chalmers, J.D. et al. Respirology, 2021
Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis
Yong-Hua, G., Abo-Leyah, H., Finch, S., et al. Am J Respir Crit Care Med, 2020
Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
Artaraz, A., Crichton, M.L., Finch, S., et al. Respir Res, 2020
Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies
Crichton, M.L., Lonergan, M., Baker, A.F., et al. Eur Respir J, 2020
Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration
Shteinberg, M., Crossley, B., Lavie, T., et al. ERJ Open Res, 2019
Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry
Dhar, R., Singh, S., Talwar, D., et al. Lancet Glob Health, 2019
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Crichton, M.L., Aliberti S., Chalmers, J.D., Eur Respir Rev, 2019
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
Sibila, O., Perea L., Cantó, E., et al. Thorax, 2019
Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis
Sibila, O., Laserna, E., Shoemark, A., et al. Am J Respir Crit Care Med, 2019
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Shoemark, A., Cant, E., Carreto, L., et al. Eur Respir J, 2019
Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
Keir, H. R., Fong, C. J., Crichton, M.L., et al. ERJ Open Res, 2019
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis
Altenburg, J., Chalmers, J.D., Lonergan, M., et al. Eur Respir J, 2019
Bronchiectasis Guidelines: Recommendations into Practice
Redondo, M., and Chalmers, J.D. Arch Bronconeumol (Engl Ed), 2019
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Laska, I.F., Crichton, M.L., Shoemark, A., et al. Lancet Respir Med, 2019
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Chalmers, J. D., Ringshausen, F. C., Harris, B., et al. Eur Respir J, 2018
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration
Aliberti, S., Polverino, E., Chalmers, J. D., et al. Eur Respir J, 2018
The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Polverino, E., Dimakou, K., Hurst, J., et al. Eur Respir J, 2018
Continuous versus intermittent antibiotics for bronchiectasis
Donovan, T., Felix, L.M., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2018
Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis
Chalmers, J.D., Alibert, S., Filonenko, A., et al. Am J Respir Crit Care Med, 2018
The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis
Geominne, P. C., Cox, B., Finch, S., et al. Eur Res J, 2018
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study
De Soyza, A., McDonnell, M. J., Goeminne, P. C., et al. Chest, 2017
Patient participation in ERS guidelines and research projects: the EMBARC experience
Chalmers, J. D., Timothy, A., Polverino, E., et al. Breathe (Sheff), 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
Chalmers, J. D., Crichton, M., Goeminne, P. C., et al. Breathe (Sheff), 2017
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P.C., McDonnell, M.J., et al. Eur Respir J, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
Hill, A.T., Haworth, C.S., Aliberti, S., et al. Eur Respir J, 2017
Neutrophil Elastase Activity is Associated with Exacerbations and Lung Functions Decline in Bronchiectasis
Chalmers, J.D, Moffitt, K. L., Suarez-Cuartin, G. et al. Am J Respir Crit Care Med, 2017
The EMBARC European Bronchiectasis Registry: protocol for an international observational study
Chalmers, J. D., Aliberti, S., Polverino, E., et al. ERJ Open Res, 2016
Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration
Aliberti, S., Masefield, S., Polverino, E., et al. Eur Respir J, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
McDonnell, M.J., Aliberti, S., Goeminne, P.C., et al. Lancet Respir Med, 2016
COPD and bronchiectasis: phenotype, endotype or co-morbidity?
Blasi, F., Chalmers, J.D., Aliberti, S. COPD, 2014